| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.34 | 7e-07 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |